As an important finding, it has been reported that the anti‐inflammatory agent colchicine, which is currently prescribed for the treatment of BS, gout, and Familial Mediterranean Fever all of which are neutrophil‐mediated inflammatory diseases, induces the expression of CLEC12A.30 Here, CLEC12A is linked to Bloom syndrome.